INTRODUCTION N
Clinicall and experimental evidence shows that diabetic patients as a group experiencee impaired wound healing. 1 " 5 The mechanisms that contribute to poor woundd healing are not fully understood. Wound healing normally proceeds throughh general stages such as haemostasis, inflammation, proliferation, epithelializationn and tissue remodeling. Many chronic wounds fail to complete alll these stages in healing. Diabeticc ulcers are usually localized on pressure points, such as the metatarsophalangeall joints, ankles or heel region. The underlying pathology consists of neuropathy,, ischemia (both macro-and microcirculatory) and infection. 6 Infectionn plays an important role in the chronicity of these ulcers, partially due too the adverse effect of diabetes on leucocyte chemotaxis. 7, 8 Venous ulceration iss characterized by a specific pathophysiology consisting of venous stasis and microcapillaryy pathology. 9 " 14 Due to the prolonged hydrostatic pressure, the capillaries,, which are originally not designed for high pressures, become dilated,, twisted and elongated and they start to leak plasma, proteins (including fibrin)) and erythrocytes in the surrounding tissue. Some capillaries become occluded,, while the blood flow in the remaining dysfunctional capillaries is hampered.. Generally, after a period of strict bedrest, these capillary changes are reversed,, and the ulcers show a healing tendency, similar to acute wounds. Basedd on the clinical observation that epithelialization can proceed normally in thesee patients as soon as the quality of the wound bed has improved, we hypothesizee that the disturbances are located in the two preceding phases, in the proliferationn phase or the inflammation/debridement phase. Thee predominant cell types in early wound healing, especially in the inflammationn and debridement phase, are lymphocytes, granulocytes and macrophages.. The major function of granulocytes in wounds is to eliminate contaminatingg bacteria. It has been known for long that lymphocytes are present inn healing wounds, 15 but their function remains a topic of interest. ,6J ' Macrophagess play a crucial regulatory role in the transition between wound inflammationn and the next phase of wound repair, granulation tissue formation. 18199 This phase is characterized by proliferation of endothelial cells andd fibroblasts and the deposition of extracellular matrix (ECM) molecules. Duringg the repair process the ECM is sequentially remodeled and rebuilt by the actionn of different cell types and their products. Fibronectinn (FN) promotes adhesion of cells to the fibrin matrix, acting as a scaffoldd for new matrix deposition, and also has chemotactic capacities that regulatee cell movement. 20 " 23 Its expression is highly upregulated in the dermis afterr wounding. Chondroitin sulphate (CS) is a disaccharide forming glycosamino-glycann (GAG) chains of different length. They are covalently attachedd to core proteins forming chondroitin sulphate proteoglycans (CSPG). :4,:ss In norma) skin CSPG are mainly found in the basement membrane, 2b2 '' but in healing wounds they are upregulated throughout the granulationn tissue during the second week of wound repair, 2 * when they provide aa temporary matrix with high hydrative capacity. Tenascin (TN) is an ECM glycoproteinn which occurs in the basement membrane and in granulation tissue. Itt is known to have an influence on cell shape, and in vitro studies showed that TNN is important for maintaining tissue homeostasis by interfering with cell migrationn and proliferation and by inhibiting cell adhesion to FN. :y Veryy little is known about the expression of these above mentioned extracellular matrixx molecules and the composition of the cellular infiltrate in chronic diabeticc wounds. Thee objective of this study was to investigate the expression of different ECM moleculess and to characterize the infiltrate composition in chronic diabetic woundss versus chronic venous ulcers and an acute wound healing model, in orderr to come to a better understanding of the process of delayed wound healing inn diabetes mellitus.
MATERIALL AND METHODS

Clinicall profile
Thiss study w^as approved by the medical ethical committee of the Academic Medicall Center, Amsterdam, The Netherlands. Patients were fully informed aboutt the purpose and consequences of this study, and subsequently gave their informedd consent. Thirteen patients with diabetic ulcers (noninsulin-dependent diabetess mellitus) with a mean age of 69.2 years admitted to the clinic or visitingg the outpatient department of our hospital were included in this study. Ass a reference we compared the results to those of 12 patients with a venous leg ulcer,, with a mean age of 76 years, and an acute wound healing model. A chronicc ulcer was defined as existing for 8 weeks or longer. Punch biopsies of 4 mmm were taken from the margin of chronic diabetic and venous ulcers with a mediann ulcer duration of respectively, 11 (range 2-60) and 6 months (range 2.5-60).. The biopsies were taken in such a manner that the epithelial margin was includedd in the central part of the biopsy. The epithelial margin can be consideredd as a reference point because normally the epithelium will grow from heree into the wound bed, only if the tissue underneath it has reached a certain levell of quality. When biopsies are taken at random from the wound bed large differencess can be encountered in the composition of the tissue.
Thee acute wound healing model was studied in three groups of patients. In healthyy agematchcd volunteers, acute wounds were made on the upper leg and woundd healing was studied at day 5, 19 and 28 postwounding (p.w.) in four patientss (mean age of patients 78.8, SD 13.3). During the study period the woundd area was covered with Opsitc (Smith & Nephew, York, UK) to establish aa moist wound environment. The donor site (upper leg) for grafting of chronic ulcerss was rebiopsied 12 and 18 months p.w. in one patient (age 64). Wound healingg 3 and 12 months after breast reduction was studied in seven patients (meann age 24.4, SD 4.4). All punch biopsies were taken under local anaesthesia. Thee biopsies were either fixed in 4% formalin phosphate-buffered saline (PBS) solution,, processed by routine histological procedures and embedded in paraffin,, or snap-frozen and stored at -80 °C until further processing.
Immunohistochemicall staining
ECMECM molecules
Polyclonall rabbit antibodies were used to detect FN (1:800, Dako, Copenhagen, Denmark)) and TN (1:400, Life Technologies, Breda, The Netherlands) using a three-stepp labeling procedure with biotinylated polyclonal swine-antibodies anti-rabbitt IgG (1:400, Dako) as second antibody followed by streptavidin biotinylatedd horseradish peroxidase (Hrp) complex (1:200, Dako). For the detectionn of CS a mouse monoclonal antibody (1:300, Sigma, St. Louis, MO) w r ass used in a two step labeling procedure with as second step Hrp conjugated goatt antibodies antimouse IgM (1:200, Dako). Diaminobenzidinc (DAB) was obtainedd from Sigma. Sectionss of 5-6 |am thickness were mounted on polylysine coated glass slides. Thee sections were deparaffmized in xylol and hydrated through graded series of ethanol.. To remove endogenous peroxidase activity the slides were incubated forr 30 minutes in a 0.3% H,0 ; /methanol solution, washed with water and PBS. Aspccificc binding of antibodies was minimized by a 15 minutes preincubation withh 10% normal goat serum (NGS) in PBS. The sections were incubated for 1 hourr at room temperature with the first antibodies and washed three times with PBS.. Subsequently, the appropriate second antibody was applied, diluted in PBS/10%% NGS. If the second antibody was biotinylated a third incubation step wass performed with the streptavidin biotin complex conjugated with horse radishh peroxidase (streptABComplex/Hrp). After extensive washing to remove nonboundd antibodies, the colour reaction was performed with DAB substrate. Finally,, the sections were counterstaincd with hematoxylin, mounted in glycergell and examined. As recommended by the manufacturers, the fixed tissuess used for the FN staining were predigested with a 0.25% pepsin 10 mM HC11 solution pH 2,5 for 30 minutes at 37°C. A pepsin predigestion of sections forr TN and CS staining diminished the specific staining signal. The sections weree examined microscopically and photographs of representative staining were takenn using an Olympus SC35 camera (Tokyo, Japan) with 64T (EPY-135) Ektachromee film (Kodak, the Netherlands). Sections of human normal skin servedd as positive controls. As negative controls, adjacent sections of the wound biopsiess were stained with nonimmune IgG from the same species and in the samee dilution as the primary antibody. No staining was noted in the negative controls. .
ECMECM quantification
FN,, CS and TN expression in the dermis of all chronic and acute wounds was quantitatedd using a score system with a five point scale (0, no expression; 1, weaklyy positive; 2, moderate; 3, strong; 4, very strong expression). All specimenss were evaluated blindly. In order to standardize the results, the intensityy of the ECM staining was correlated to the expression found in the positivee control sections. To check reproducibility, the slides were examined by twoo independent observers, which yielded a correlation coefficient of > 0.83.
Lymphocytes,Lymphocytes, granulocytes and macrophages
Immunohistochemicall single staining was performed for the identification of T cellss (CD3 pan T-cells; 1:50; Becton Dickinson), B cells (CD20 1:1000; Dako), plasmaa cells (CD79a 1:50; Dako), granulocytes (CD 15 1:50; Becton Dickinson) andd monocytes, macrophages (CD68 1:2000; Dako) based on a three-step indirectt peroxidase technique. Cryostat sections (6 |im) were allowed to dry overnightt before fixing in acetone for 10 minutes at room temperature. Endogenouss peroxidase activity was blocked with 0.1 % sodium azide and 0.3% H 2 0 22 in phosphate buffered saline (PBS) for 10 minutes at room temperature. Forr plasma cells, paraffin-embedded tissue sections were deparaffinized in xyloll and hydratcd through a graded series of ethanol. To remove endogenous peroxidasee activity the slides w r ere incubated for 30 minutes in a 0.3% H 2 0 2 /methanoll solution, washed with water and PBS. Antigen retrieval was achievedd by boiling the sections in 10 mM Citrate buffer; PH 6.0 (Dako). Aspecificc binding of antibodies was minimized by a 15 minutes preincubation withh 10% NGS in PBS. Briefly, the sections were incubated sequentially with primaryy antibody for 60 minutes followed by an incubation with biotinylated secondaryy monoclonal rabbit antimouse antibody (30 minutes). This was followedd by an incubation of 30 minutes with streptABComplex/Hrp (1:400 Dako).. Before counterstaining with haematoxylin, the horseradish peroxidase activityy was visualized with 3-atnino-9-ethylcarbazole (AEC; Sigma) as chromogenn for cryostat sections and with DAB substrate for the paraffin sections. . Forr immunohistochemical double staining the following steps were performed : (i)) incubation of 60 minutes with a cocktail of rabbit antihuman CD3 plus either mousee antihuman CD4 (1:20; Becton Dickinson) or mouse antihuman CD8 (1:200 Becton Dickinson); (ii) an incubation of 30 minutes with a cocktail of biotin-conjugatedd goat anti-mouse (1:200; Dako) plus alkaline phosphataseconjugatedd goat anti-rabbit (1:10; Dako) and an incubation of 30 minutes with streptABCornplex/Hrpp (1:400; Dako). Alkaline phosphatase was detected as bluee colour, using naphthol-AS-MX-phosphate as a substrate and fast blue BB (Sigma)) as azo dye. Peroxidase activity was detected as an orange red colour, usingg the chromogen AEC. Double staining cells were detected by their purple colour.. The staining reaction was visually controlled and stopped by washing. Sectionss were finally fixed in formaldehyde (4%) and mounted with glyceringelatinn without counterstaining. Sections of human tonsils served as positive controls.. The negative controls were stained in the same manner as all specimen withoutt incubation with the primary antibodies.
CellCell enumeration
Thee number of single or double stained cells of three different serial sections of eachh wound were counted (blinded) up to a depth of 1 mm. These values of eachh biopsy specimen were adjusted to 10 mm width. The mean value of each biopsyy was used for further analysis.
Statisticall evaluation
Thee unpaired Student's Mest was used for statistical evaluation of differences in thee composition of the cellular infiltrate between each group. To detect the significancee of differences in the CD4/CD8 ratio's and the number of B-cells andd plasma cells between acute and chronic wounds, the Mann-Whitney U test wass used. P -values < 0.05 (two-tailed) were considered significant.
RESULTS S Extracellularr matrix characterization
Fibronectin Fibronectin
Inn normal skin fibronectin could only be detected in bloodvessels (Fig. 1A) . In sectionss of biopsies taken 19 days p.w. FN (Fig, IB) was clearly present in the dermis.. In time. FN staining increased markedly until 3 months p.w. (Fig, 1C ) too gradually decline towards 12-18 months p.w. (Fig. ID) . In chronic diabetic ulcerss with a ulcer duration of more than 12-18 months, and in two venous ulcers,, expression of FN was still noted in the whole dermis of the ulcer area ( Fig.. IF) .
ChondroitinChondroitin sulpha!e CSS labeling in normal skin was found in the basement membrane (BM) and in thee periphery of vascular structures ( Fig. 2A) . CS was detected after 19 days p.w.. in the dermal tissue of acute wounds (Fig, 2B ) and its expression became moree intens up to 3 months p.w. (Fig. 2C) . At 12 to 18 months p.w. CS staining inn the dermis of all acute wounds was back to prewounding levels (Fig. 2D ). All 255 chronic wounds showed high CS expression in the dermis and basement membranee ( Fig. 2E.F) .
Tenascin Tenascin
Inn normal skin, TN staining was seen as a patch wise distribution in the BM zonee ( Fig. 3A) . At 19 days p.w, TN started to be expressed in the wound edge withh the BM zone of the healthy skin being positive ( Fig. 3B) . At 3 months p.w.strongg expression of TN was seen in the dermis (Fig. 3C ) which returned to prewoundingg levels at 12 months (Fig. 3D ). The chronic wounds showed a light,, moderate or strong expression of TN in the dermis with great variability amongg the ulcers. For diabetic ulcers two showed no ( Fig. 3E ) and two showed weakk expression, four moderate, three strong and one very strong TN expressionn (Fig. 3F ) in the dermis. Among venous ulcers three showed no expression,, two light, two moderate and two strong expression. Fig. 4 (B,C) , all chronic ulcers and their dermal CS and TN expression aree visualized versus the acute wound healing model. There was a trend of prolongedd CS and TN expression in the dermis of venous and diabetic wounds withh a duration of more than 12 months. Lymphocytes,Lymphocytes, granulocytes and macrophages AA common observation in chronic wounds was a hyperkeratotic epidermis at the woundd edge with necrotic wound tissue heavily infiltrated with inflammatory cells.. Fig. 5 shows the kinetics of T and B cells, plasma cells, macrophages and granulocytess in acute and chronic wounds represented by CD3 (Pan T cells), CD44 (helper-inducer T cells) CD8 (suppressor-cytotoxic T cells), CD 15 (granulocytes),, CD20 (B cells), CD79a (plasma cells) and CD68 (monocytes, macrophages)) positive cells. In the early stage of wound healing, there is an influxx of T cells which were predominantly of the CD3 + CD4 + type (Fig. 5A,B ). Inn chronic wounds T-cells were present although in a lower number than in the acutee wound healing model at any day (p < 0.0048 for venous ulcers and p < 0.022 for diabetic ulcers). This was mainly caused by a significantly lower numberr of CD3 CD4 positive T cells in chronic wounds (p < 0.0028 for venous ulcers,, p < 0.0029 for diabetic ulcers) whereas the number of CD8+ T cells did nott change dramatically (Fig. 5C ). CD4/CD8 ratio's in acute wounds varied betweenn 4.9 and 9.7 (Table II) . In chronic wounds the CD4/CD8 ratio was significantlyy depressed, p < 0.0027, compared to any day in the acute wound healingg model. Granulocytes increased rapidly in number during the early phase afterr wounding and decreased again after 5 days p.w.; they remained present in chronicc wounds (Fig. 5D) . B cells were detected at all time points in acute woundss with a peak at day 19. B cells were present in significantly higher numberss in both chronic wounds. In venous ulcers a mean B cell number of 750 wass found whereas at day 5, 19 and 28 p.w. there was a maximum of 200 B cellss (p<0.04). This was also true for the diabetic ulcers (p < 0.006) (Fig. 5E ). Plasmaa cells were detected in significantly higher numbers (p < 0.0121) in both typess of chronic wounds compared to any day in the acute wound healing modell (Fig. 5F ). Macrophages appeared together with T lymphocytes in the initiall phase of wounding in high numbers and in time their number decreased. Thee number of macrophages in both chronic wounds was significantly higher (diabeticc ulcers, p < 0.0011 and venous ulcers, p < 0.00001) compared to the lastt time point (day 28 p.w.) of the acute wound healing model (Fig. 5G ).
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Figuree 5. Reduced numbers of CD4' T cells andd high numbers of B cells, plasma cells andd macrophages in chronic diabetic and venouss ulcers compared to the acute woundd healing model. Kinetics of T cells representedd by CD3'. CD4' and CD8' cells (a-c)(a-c) tt
DISCUSSION N
Thee purpose of this study in a broader perspective was to find an explanation on thee cellular or molecular level for the clinical observation that wound healing is delayedd in diabetes mellitus. Inn normal wound healing, the consecutive phases such as hemostasis, inflammationn and debridement, proliferation and remodeling, can be identified byy characteristic patterns of cellular infiltrate and ECM deposition. Most chronicc diabetic and venous ulcers fail to complete all these stages of normal woundd healing. We hypothesized that the disturbances are located in the proliferationn phase and/or the inflammation and debridement phase. Once these phasess have been completed successfully, uncomplicated epithelialization will usuallyy follow. Wee observed a prolonged expression of FN, CS and TN in patient material from 133 chronic diabetic ulcers and 12 venous ulcers, with a duration of more than 12 months.. Although a semiquantitative evaluation method was used to detect thesee ECM molecules, the statement that this is an abnormal finding is valid becausee normally these matrix molecules should only be present early in wound healing. . CSS expression, investigated using a monoclonal antibody that can detect all CSPGG because it recognizes the GAG chains attached to the core protein, e.g., decorin,, CS-basement membrane proteoglycan, and biglycan, was present far beyondd the normal time frame of expression seen in normal wound healing. CSPGG expression has been shown to be indicative for different stages of ECM regenerationn and remodeling in a porcine wound model. 30 Abnormall patterns of FN and TN expression have also been observed by other groups.. Latijnhouwers et al. 31 reported a variable, but mostly upregulated TN expressionn in the papillary dermis adjacent to the ulcer base of chronic venous ulcers.. Ferguson et al. 32 demonstrated the presence of small abnormal blood vesselss at the wound edge and base of diabetic ulcers, sometimes cuffed with collagen,, laminin, FN and fibrin. Herrick et al. 14 showed a upregulated TN and FNN expression in the ulcer margin and a weak positive ulcer base for TN and thee absence of FN in the ulcer base of venous ulcers. The distribution of TN duringg wound healing has been studied in animal models and to a lesser extent inn human skin. TN has been reported to be upregulated primarily in the first two weekss p.w., first in the dermal areas adjacent to the wound bed and later in the woundd bed, 31 to gradually disappear after 1.5 months. 33 A strong but transient increasee in TN expression (maximum at 4 days p.w., towards baseline at day 11)) has been described in rats.'" Studiess on the composition of the cellular infiltrate in chronic wounds are scarce.. An explanation might be that patient material is difficult to obtain for practicall and ethical reasons. Severall hypotheses have been proposed to explain delayed wound healing in diabetes,, such as glycosylation of important structural proteins and growth factors,, a possible deficit in specific growth factor production or release into the wound 55 and impairment of leucocyte 8 or macrophage function. 35 Some of these mechanismss may be related.
Glycosylation n
Inn diabetes it has been postulated that excessive formation of advanced glycosylatedd end products in the presence of continuously elevated blood glucosee may overwhelm the body's ability to remove them, resulting in a net excesss of advanced glycosylated end products on most of the structural proteins, leadingg to an altered recognition by their cellular receptors. 36 The absence of a negativee feedback mechanism may lead to overproduction of ECM. It has been shownn in vitro that exposure of mesangial cells to advanced glycosylated end productss was followed by an increase in mRNA for laminin, collagen IV, and heparann sulphate, and FN production, which is the hallmark of glomerulosclerosis,, and a decrease in cellular proliferation. 37,3R The mechanisms thatt lead to nephropathy in diabetes may be similar to those leading to delayed woundd healing.
Growthh factors/cytokines
Thee observed expression of FN, CS and TN in the edge of chronic wounds showss that there is a potential to heal since it is a natural pattern of acute woundss to express these molecules at the onset of the healing process. Normally fibroblastss eventually cease to produce these provisional ECM molecules, possiblyy by inhibitory growth factors that are secreted in the next phase of woundd healing, granulation tissue formation. An imbalance of cytokines in the chronicc wound bed or edge and the presence of inflammatory cells could be responsiblee as well for the continued production of ECM molecules. ECM degradationn is also taking place: FN degradation products have been observed inn chronic skin ulcers 39 " 41 as well as elevated levels of several proteinasesgeiatinasesgeiatinases in wound fluid. 42 ' 43 It seems that in these chronic nonhealing ulcers bothh excess deposition of E CM molecules and increased proteolytic activity againstt ECM molecules are present. TGF-B and activated CD4 + T lymphocytes havee been shown to trigger synovial fibroblasts and epitenon cells to increase theirr production of FN. 44 499 found a relatively low number of B cells in the edge of venous ulcers comprisingg less than 3% of the dermal infiltrate. We biopsied chronic ulcera in aa non-healing stage, and a continuous exposition to bacteria might be responsiblee for the increased number of B cells.. The observation that significantlyy more plasma cells were present in the chronic ulcers also supports thiss hypothesis, because a plasmaeellular infiltrate is often associated with the presencee of micro-organisms. Macrophagess appear together with T cells in the initial phase of wound healing. Theyy play a key role in the transition from the inflammatory phase to the proliferatingg phase. 50 ' 51 Although macrophages dominate the ulcer edge of both diabeticc and venous ulcers, they seem to be unable to direct the repair process towardss the proliferative phase. Our finding is in concordance with the results off one other study on phenotyping of immunocompetent cells in venous leg ulcers. 499 These authors also showed that the venous ulcer edge was mainly populatedd by macrophages. Recently, Moore and coworkers reported that monocytess appeared to be active perivascular in venous ulcers but while penetratingg the wound bed as macrophages they lost their activation markers. 15 Inn summary', there appears to be a disturbance in the phase of inflammation and debridementt and in the proliferation phase Distinct patterns of ECM deposition andd a different composition of the cellular infiltrate were observed in chronic diabeticc and venous ulcers Although both chronic wound types have a different pathophysiology,, the observed abnormalities in ECM quantification and infiltratee nnmuriophenotyping are very comparable While m acute wounds the inflammatoryy phase is of short duration and directed at removal of bacteria and deadd tissue, with polymorphonuclear leucocytes and macrophages as the predominantt cell types, in chronic wounds there is a prolonged and increased presencepresence of a T cell infiltrate, with an abnormal CD4 CD8 balance, and an increasedd number of macrophages, without any evidence of increased autodigestionn and phagocytosis These chronic venous and diabetic ulcers seem too be frozen in a chronic low-grade inflammatory state, in the sense that completionn of the digestive tasks and transition into the next phase, proliferation off fibroblasts and endothelial cells,, is not taking place Similarr remarks can be made regarding the proliferation phase large amounts off ECM molecules are being produced but the composition resembles the patternn seen in late phases (2 3 months) ol normal wound healing The moleculess are not removed or remodeled within a normal timeframe as in acute woundss In tact, the composition of the ECM and cellular infiltrate share propertiess of both the inflammatory phase and prohfeiation phase, and it is likelyy that the classification criteria that we use to define healing stages in acute woundss are not applicable at all in chronic leg ulcers
